Papers

Setting the stage for biosimilar monoclonal antibodies

Schneider CK et al. Setting the stage for biosimilar monoclonal antibodies. Nature Biotech. 2012;30:1179-85.

Abstract

With the first marketing authorization application for a biosimilar monoclonal antibody now under consideration at the European Medicines Agency, what are the critical issues for regulators?

Click for full article

Subscribe for updates

EXPLORE OUR BIOANALYTICAL PLATFORMS

See how we apply our specialized large molecule expertise to help solve your bioanalytical challenges.


View Services

Analytical Assays Determine Biosimilar Product Quality

READ THE ARTICLE

Pharmacokinetics & Pharmacodynamics​

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.
220328 Adleverage_Scientific Icon Illustrations_#46-65_CO_Per FIles